Hu Immunolabeling as a Marker of Neural and Neuroendocrine Differentiation in Normal and Neoplastic Human Tissues: Assessment Using a Recombinant Anti-Hu Fab Fragment

Abstract

The recombinant antibody fragment Fab GLN 495 recognizes an epitope shared by members of the neuron-associated Hu protein family (including HuC, HuD, and HelNI). This novel reagent labels the nuclei of neurons throughout the peripheral and central neuraxes and has been shown to recognize pulmonary small cell carcinomas and central nervous system (CNS) tumors of mature neuronal phenotype or neuronogenic differentiating capacity. Using this Fab fragment, we have undertaken a systematic survey of normal human tissues and an assessment of 554 non-CNS tumor samples for immunohistochemical evidence of Hu expression. Adrenomedullary cells, pancreatic islet cells, paraganglial chief cells, isolated adenohypophyseal cells, and spermatogonia were the only nonneuronal normal tissue elements to bind Fab GLN 495. In addition to labeling all 10 small cell carcinomas studied (six of which were extrapulmonary in origin), this recombinant anti-Hu Fab proved immunoreactive with neuroblastomas (four/four), esthesioneuroblastomas (one/one), typical (three/four) and atypical (one/four) pulmonary carcinoids, pancreatic islet cell tumors (two/six), large-cell neuroendocrine carcinoma of lung (one/four), Merkel cell tumors (two/three), medullary carcinomas of the thyroid (four/six), pheochromocytomas (two/four) and paragangliomas (four/four). Nonneural/neuroendocrine tumor labeling was restricted to the neuronal and immature neuroepithelial components of teratomas, to extraskeletal myxoid chondrosarcomas (three/four) and to small subsets of cells within examples of renal rhabdoid tumor (one/four), desmoplastic small cell tumor (one/four), alveolar rhabdomyosarcoma (two/four), Ewing sarcoma/PNET (two/nine), and Wilms tumor (one/four). Immunoreactivity was principally nuclear, with variable cytoplasmic labeling. Our findings support the largely restricted expression of Hu by neural/neuroendocrine neoplasms, suggest a potential role for Fab GLN 495 in the identification of small cell carcinomas irrespective of primary site, and support a recent proposal that at least some extraskeletal myxoid “chondrosarcomas” actually represent neuroendocrine tumors of soft parts.

Keywords

Anti-Hu antineuronal autoantibodies recombinant antibodies human tumors neuroendocrine tumors paraneoplastic syndromes small cell carcinoma

Get full access to this article

View all access options for this article.

References

1. Altermatt HJ , Rodriguez M , Scheithauer BW , Lennon VA . Paraneoplastic anti-Purkinje and type 1 antineuronal nuclear autoantibodies bind selectively to central, peripheral and autonomic nervous system cells. Lab Invest 65:412-420, 1991

2. Graus F , Cordon-Cardo C , Posner JB . Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538-543, 1985

3. Rosenblum MK . Paraneoplasia and autoimmunologic injury of the nervous system: The anti-Hu syndrome. Brain Pathol 3:199-212, 1993

4. Barami K , Iversen K , Furneaux H , Goldman SA . Hu protein as an early marker of neuronal phenotypic differentiation by subependymal zone cells of the adult songbird forebrain. J Neurobiol 28:82-101, 1995

5. Gao FB , Keene JD . Hel-NI/Hel-N2 proteins are bound to Poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci 109:579-589, 1996

6. Marusich MF , Furneaux HM , Henion PD , Weston JA . Hu neuronal proteins are expressed in proliferating neurogenic cells. J Neurobiol 25:143-155, 1994

7. Szabo A , Dalmau J , Manley G , Rosenfeld M , Wong E , Henson J , Posner JB , Furneaux HM . HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325-333, 1991

8. Dalmau J , Furneaux HM , Cordon-Cardo C , Posner JB . The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 141:881-886, 1992

9. Manley GT , Smitt PS , Dalmau J , Posner JB . Hu antigens: Reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol 38:102-110, 1995

10.

10. Dalmau J , Graus F , Cheung N-KV , Rosenblum MK , Ho A , Cafiete A. Delattre J-Y , Thompson SJ , Posner JB . Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75:99-109, 1995

11.

11. Gultekin SH , Dalmau J , Graus Y , Posner JB , Rosenblum MK . Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors: A study of 112 central neuroepithelial neoplasms. Am J Surg Pathol 22:195-200, 1998

12.

12. Laeng RH , Scheithauer BW , Altermatt HJ . Anti-neuronal nuclear autoantibodies, types 1 and 2: Their Utility in the study of tumors of the nervous system. Acta Neuropathol 96:329-339, 1998

13.

13. Graus YF , Verschuuren JJ , Degenhardt A , van Breda Vriesman PJ , De Baets MR , Posner JB , Burton DR , Dalmau J. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis. J Neuroimmunol 82:200-209, 1998

14.

14. Battifora H. The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 55:244-248, 1986

15.

15. Abe R , Uyeno Y , Yamamoto K , Sakamoto H. Tissuespecific expression of the gene encoding a mouse RNA binding protein homologous to human HuD antigen. DNA Res 1:175-180, 1994

16.

16. Russo AF , Clark MS , Durham PL . Thyroid parafollicular cells. An accessible model for study of serotonergic neurons. Mol Neurobiol 13:257-276, 1996

17.

17. Lauriola L , Erlandson RA , Rosai J. Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol 22:1059-1066, 1998

18.

18. Fischer HP , Thomsen H , Altmannsberger M , Bertram U. Malignant rhabdoid tumour of the kidney expressing neurofilament proteins. Immunohistochemical findings and histogenetic aspects. Pathol Res Pract 184:541-547, 1989

19.

19. Gerald WL , Ladanyi M , de Alava E , Rosai J. Desmoplastic small round-cell tumor. A recently recognized tumor type associated with a unique gene fusion. Adv Anat Pathol 2:341-345, 1995

20.

20. Magee F , Mah RG , Taylor GP , Dimmick JE . Neural differentiation in Wilms'tumor. Hum Pathol 18:33-37, 1987

21.

21. Miettinen M , Rapola J. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and the 68-kD neurofilament protein. Am J Surg Pathol 13:120-132, 1989

22.

22. Molenaar WM , Muntinghe FLH . Expression of neural-cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumors. Hum Pathol 29:1290-1293, 1998

23.

23. Abenoza P , Wick MR . Primitive cerebral neuroectodermal tumor with rhabdomyoblastic differentiation. Ultrastruct Pathol 10:347-354, 1986

24.

24. Roa I , Araya J , Gonzalez S , Garrido C. Peripheral pigmented neuroectodermal tumor of infancy with rhabdomyoblastic differentiation. Pathol Res Pract 186:403-407, 1990

25.

25. Roncaroli F , Montironi R , Feliciotti F , Losi L , Eusebi V. Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol 19:217-223, 1995

26.

26. Slootweg PJ , Lubsen H. Rhabdomyoblasts in olfactory neuroblastoma. Histopathology 19:182-184, 1991

27.

27. Carter RL , al-Sams SZ , Corbett RP , Clinton S. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children. Histopathology 16:461-467, 1990

28.

28. Dierick AM , Roels H , Langlois M. The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis. Pathol Res Pract 189:26-32, 1993

29.

29. Shanfeld RL , Edelman J , Willis JE , Tuason L , Goldblum JR . Immunohistochemical analysis of neuronal markers in peripheral primitive neuroectodermal tumors (pPNET) without light microscopic evidence of neural differentiation. Appl Immunohistochem 5:78-86, 1997

30.

30. Ladanyi M , Heinemann FS , Huvos AG , Rao PH , Chen QG , Jhanwar SC . Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(1;22) (q24;ql2): An immunohistochemical study of 11 cases. Hum Pathol 21:1245-1251, 1990

31.

31. Llombart-Bosch A , Carda C , Peydro-Olaya A , Noguera R , Perez-Bacete M , Pellin A , Boix J . Soft tissue Ewing's sarcoma. Characterization in established cultures and xenografts with evidence of a neuroectodermal phenotype. Cancer 66:2589-2601, 1990

32.

32. Henion PD , Weston JA . Timing and pattern of cell fate restrictions in the neural crest lineage. Development 124:4351-4359, 1997

33.

33. Eusebi V , Mambelli V , Tison V , De Lellis R , Betts CM . Endocrine differentiation in basal cell carcinoma. Tumori 65:191-199, 1979

34.

34. Verschuuren J , Twijnstra A , De Baets M , Thunnissen F , Dalmau J , van Breda . Hu antigens and anti-Hu antibodies in a patient with myxoid chondrosarcoma. Neurology 44:1551-1552, 1994

35.

35. Chhieng DC , Erlandson RA , Antonescu C , Ladanyi M , Rosai J. Neuroendocrine differentiation in adult soft tissue sarcomas with features of extraskeletal myxoid chondrosarcoma: Report of seven cases. Mod Pathol 11: 8A-8A, 1998